Cite
HARVARD Citation
Moy, B. et al. (2021). Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update. Journal of clinical oncology. 39 (35), pp. 3938-3958. [Online].